These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 13931219)

  • 41. [THE PROBLEM OF THE SPECIFICITY OF GUANIDINE FOR THE DEVELOPMENT OF A GUANIDINE-REQUIRING MUTANT OF POLIOVIRUS].
    LWOFF A; LWOFF M; KOCH A
    C R Hebd Seances Acad Sci; 1963 Dec; 257():4068-70. PubMed ID: 14101445
    [No Abstract]   [Full Text] [Related]  

  • 42. [RESEARCH ON THE NATURE OF THE GUANIDINE RESISTANCE OF TYPE 1 POLIOVIRUS AND ON THE BIOLOGICAL PROPERTIES OF ITS MUTANTS].
    HORODNICEANU F; SERGIESCO D; KLEIN R; ZAMFIRESCO M; AUBERT-COMBIESCO A; BRUCKER I
    Arch Roum Pathol Exp Microbiol; 1963 Sep; 23():719-24. PubMed ID: 14165851
    [No Abstract]   [Full Text] [Related]  

  • 43. [NEUTRALIZATION BY VARIOUS METABOLITES OF THE INHIBITOR EFFECT OF GUANIDINE ON DEVELOPMENT OF THE POLIOVIRUS].
    LWOFF A; LWOFF M
    C R Hebd Seances Acad Sci; 1964 Jul; 259():949-52. PubMed ID: 14190540
    [No Abstract]   [Full Text] [Related]  

  • 44. CHARACTERS OF GUANIDINE RESISTANT MUTANTS OF TYPE 1 POLIOVIRUS.
    HORODNICEANU F; SERGIESCU D; KLEIN R; ZAMFIRESCU M; COMBIESCU AA
    Arch Gesamte Virusforsch; 1964; 14():238-52. PubMed ID: 14141583
    [No Abstract]   [Full Text] [Related]  

  • 45. A STUDY OF THE MUTATION RATES OF SEVERAL POLIOVIRUS STRAINS TO THE REPRODUCTIVE CAPACITY TEMPERATURE/40+ AND GUANIDINE MARKER CHARACTERISTICS.
    CARP RI
    Virology; 1963 Nov; 21():373-82. PubMed ID: 14081361
    [No Abstract]   [Full Text] [Related]  

  • 46. STUDIES ON THE GUANIDINE CHARACTER OF POLIOVIRUS.
    CARP RI
    Virology; 1964 Feb; 22():270-9. PubMed ID: 14165332
    [No Abstract]   [Full Text] [Related]  

  • 47. THE DEVELOPMENT OF ULTRAVIOLET-IRRADIATION RESISTANCE BY POLIOVIRUS INFECTIVE CENTERS AND ITS INHIBITION BY GUANIDINE.
    EGGERS HJ; IKEGAMI N; TAMM I
    Virology; 1965 Mar; 25():475-8. PubMed ID: 14328617
    [No Abstract]   [Full Text] [Related]  

  • 48. [EFFECTS OF GUANIDINE AND UREA ON VARIOUS SENSITIVE, RESISTANT AND REQUIRING POLIOVIRUS STRAINS].
    LWOFF A; LWOFF M; KOCH A
    C R Hebd Seances Acad Sci; 1963 Dec; 257():3702-4. PubMed ID: 14102051
    [No Abstract]   [Full Text] [Related]  

  • 49. Variants of Poliovirus hominis. 3. Peaks of onset of paralysis with a newly isolated type II strain (R980).
    DORMAN DC; LARKIN M; PONSFORD J; STANLEY NF
    Aust J Exp Biol Med Sci; 1956 Aug; 34(4):293-6. PubMed ID: 13363761
    [No Abstract]   [Full Text] [Related]  

  • 50. Potentiating effect of 5-fluorouracil on the in vitro antipoliovirus activity of guanidine.
    LODDO B; FERRARI W; SPANEDDA A; BROTZU G
    Nature; 1963 Jan; 197():408-9. PubMed ID: 13931212
    [No Abstract]   [Full Text] [Related]  

  • 51. In vitro guanidino-resistance and guanidino-dependence of poliovirus.
    LODDO B; FERRARI W; SPANEDDA A; BROTZU G
    Experientia; 1962 Nov; 18():518-9. PubMed ID: 13931214
    [No Abstract]   [Full Text] [Related]  

  • 52. [A POLIOVIRUS MUTANT INSENSITIVE TO THE EFFECTS OF DEUTERATION].
    LWOFF A; LWOFF M
    C R Hebd Seances Acad Sci; 1964 Mar; 258():2702-4. PubMed ID: 14141675
    [No Abstract]   [Full Text] [Related]  

  • 53. Depression of host-controlled RNA synthesis in human cells during poliovirus infection.
    HOLLAND JJ
    Proc Natl Acad Sci U S A; 1963 Jan; 49(1):23-8. PubMed ID: 13961306
    [No Abstract]   [Full Text] [Related]  

  • 54. [Pleiotropy of guanidine mutations of the poliomyelitis virus].
    Agol VI; Tol'skaia EA; Voroshilova MK
    Dokl Akad Nauk SSSR; 1965 Sep; 164(2):433-6. PubMed ID: 4288984
    [No Abstract]   [Full Text] [Related]  

  • 55. Poliovirus-induced RNA polymerase and the effects of virus-specific inhibitors on its production.
    BALTIMORE D; EGGERS HJ; FRANKLIN RM; TAMM I
    Proc Natl Acad Sci U S A; 1963 Jun; 49(6):843-9. PubMed ID: 13966259
    [No Abstract]   [Full Text] [Related]  

  • 56. ANTI-VIRAL ACTIVITY OF TWO GUANIDINE DERIVATIVES IN VITRO.
    LODDO B; GESSA GL
    Nature; 1965 Jan; 205():401-2. PubMed ID: 14243432
    [No Abstract]   [Full Text] [Related]  

  • 57. Paralysis after oral poliomyelitis vaccine.
    HINTON GG; DUNCAN IB; RATHBUN JC
    Can Med Assoc J; 1962 Oct; 87(17):915-6. PubMed ID: 13954690
    [No Abstract]   [Full Text] [Related]  

  • 58. POTENTIATION OF AMINO ACID ANTAGONISTS ON ANTIVIRAL EFFECT OF GUANIDINE.
    UEDA T; TOYOSHIMA S; TAKADA A; SETO Y
    Keio J Med; 1963 Sep; 12():131-7. PubMed ID: 14079731
    [No Abstract]   [Full Text] [Related]  

  • 59. Lack of direct correlation between p220 cleavage and the shut-off of host translation after poliovirus infection.
    Pérez L; Carrasco L
    Virology; 1992 Jul; 189(1):178-86. PubMed ID: 1604809
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of amino acid residue 187 of poliovirus polypeptide 2C in determining the guanidine trait.
    Baltera RF; Tershak DR
    Intervirology; 1992; 33(3):165-72. PubMed ID: 1323552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.